reference/11285631

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11285631

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1176
issn	1935-5548 0149-5992
issueIdentifier	7
pageRange	1170-1176
publicationName	Diabetes Care
startingPage	1170
bibliographicCitation	Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study. Diabetes Care. 2009 Jul;32(7):1170–6. PMID: 19389820; PMCID: PMC2699706.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfb2a2a0f6bfb69c5718cbe1262a5302 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20b5160bf84dc1fb1a725e7b28e411bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_940c11cdcd9b0746c89c713fd50dcc33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1594c8857247cc29ddf60213bd5b2844 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1756-661X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e858f7491ef71f3e17cce900f10f4494 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93a4aca123eb8e4e0ae2687b62e8523a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d9b59959edd4c80e8d143d2befae151 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a8f3c9b4d19c8b3078a3ca48d9d98c4
date	2009-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19389820 https://doi.org/10.2337/dc08-1874 https://pubmed.ncbi.nlm.nih.gov/PMC2699706
isPartOf	https://portal.issn.org/resource/ISSN/1935-5548 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3416 https://portal.issn.org/resource/ISSN/0149-5992
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study
discusses	http://id.nlm.nih.gov/mesh/M0011417 http://id.nlm.nih.gov/mesh/M0465327 http://id.nlm.nih.gov/mesh/M0556909 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0010114 http://id.nlm.nih.gov/mesh/M0361589
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003922Q000188 http://id.nlm.nih.gov/mesh/D007328Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007328Q000627 http://id.nlm.nih.gov/mesh/D017668 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D007328Q000009 http://id.nlm.nih.gov/mesh/D007328Q000008 http://id.nlm.nih.gov/mesh/D000069036 http://id.nlm.nih.gov/mesh/D006442Q000187 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D001786Q000378 http://id.nlm.nih.gov/mesh/D007004Q000009 http://id.nlm.nih.gov/mesh/D061268 http://id.nlm.nih.gov/mesh/D001786Q000187 http://id.nlm.nih.gov/mesh/D007004Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D049528 http://id.nlm.nih.gov/mesh/D007700 http://id.nlm.nih.gov/mesh/D007003Q000453 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006442Q000378 http://id.nlm.nih.gov/mesh/D007279 http://id.nlm.nih.gov/mesh/D007332
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1ef7af3407e96ea02497b2009be8786 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7442 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127796644

Total number of triples: 70.